These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 19321593

  • 1. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome.
    Bagnoli M, Ambrogi F, Pilotti S, Alberti P, Ditto A, Barbareschi M, Galligioni E, Biganzoli E, Canevari S, Mezzanzanica D.
    Endocr Relat Cancer; 2009 Jun; 16(2):443-53. PubMed ID: 19321593
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1487-93. PubMed ID: 16533772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
    Hornung R, Urs E, Serenella E, Edward W, Ursula S, Urs H, Daniel F.
    Cancer Lett; 2004 Mar 31; 206(1):97-106. PubMed ID: 15019165
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar 31; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
    Ullenhag GJ, Mukherjee A, Watson NF, Al-Attar AH, Scholefield JH, Durrant LG.
    Clin Cancer Res; 2007 Sep 01; 13(17):5070-5. PubMed ID: 17785559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov 01; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 12. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick MB.
    Gynecol Oncol; 2006 Jan 01; 100(1):152-9. PubMed ID: 16198399
    [Abstract] [Full Text] [Related]

  • 13. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD, Kanbour AI, Price FV, Finkelstein SD, Christopherson WA, Seski JC, Naus GJ, Burnham JA, Kanbour-Shakir A, Edwards RP.
    Cancer; 1997 Apr 15; 79(8):1587-94. PubMed ID: 9118043
    [Abstract] [Full Text] [Related]

  • 14. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ, Qiao YH, Suo ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):848-52. PubMed ID: 19173831
    [Abstract] [Full Text] [Related]

  • 15. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun 15; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 16. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L, Yang K.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb 15; 34(2):101-4. PubMed ID: 11263193
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.
    Tanabe H, Nishii H, Sakata A, Suzuki K, Mori Y, Shinozaki H, Watanabe A, Ochiai K, Yasuda M, Tanaka T.
    Gynecol Oncol; 2004 Sep 15; 94(3):735-9. PubMed ID: 15350366
    [Abstract] [Full Text] [Related]

  • 18. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A, Schindl M, Kohlberger P, Lahodny J, Breitenecker G, Horvat R, Birner P.
    Gynecol Oncol; 2004 Feb 15; 92(2):545-52. PubMed ID: 14766246
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of p53 accumulation in epithelial ovarian carcinomas.
    Berker B, Dunder I, Ensari A, Cengiz SD.
    Arch Gynecol Obstet; 2002 Aug 15; 266(4):205-9. PubMed ID: 12192480
    [Abstract] [Full Text] [Related]

  • 20. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan 15; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.